Harm Reduction Therapeutics Inc

Throughout 2024, Harm Reduction Therapeutics (HRT) continued its work as an independent nonprofit focused exclusively on saving lives that would otherwise be lost to opioid overdose by making its naloxone product - rivive (naloxone hcl nasal spray 3mg) - available over- the-counter (otc) free of charge or at the lowest possible cost. Rivive uses an easy-to-use standard intranasal sprayer that can be used in an emergency to reverse the life- threatening effects of known or suspected opioid overdose. Each rivive nasal spray device contains one dose of naloxone. It is exclusively available in twin packs containing two single-dose devices. It is safe to keep administering rivive every two to three minutes until the person wakes up from their opioid overdose. As has always been and will always be the case, no company, entity, or individual profits from sales of rivive. Since we began our work in 2017, over 500,000 americans have died of an opioid overdose. 2024 marked an important milestone